共 50 条
[21]
Decrease in body weight with once-daily atogepant for the preventive treatment of migraine: A post hoc analysis
[J].
HEADACHE,
2022, 62
:96-97
[25]
Efficacy of Oral Atogepant in People With Chronic Migraine With and Without Acute Medication Overuse: Results From the PROGRESS Trial
[J].
HEADACHE,
2023, 63
:136-136
[26]
Atogepant Provides Early Improvements in Daily Functioning and Quality of Life: Results from the PROGRESS Chronic Migraine Trial
[J].
HEADACHE,
2023, 63
:117-118
[29]
Monthly migraine days, acute medication use days, and migraine-specific quality of life in responders to atogepant: A post hoc analysis
[J].
HEADACHE,
2022, 62
:152-153
[30]
Safety and tolerability of atogepant for the preventive treatment of migraine: a post hoc analysis of pooled data from four clinical trials
[J].
The Journal of Headache and Pain,
25